News Coverage
This article relates to the FCS+T Group property:
Illinois Science + Technology Park
Aseptic Filling Adjusting to New Paradigm
By Angelo DePalma, Ph.D., Genetic Engineering & Biotechnology News
Aseptic filling—the final step before packaging parenteral small molecule and biotherapeutic drugs—represents one of the most technologically innovative and dynamic areas of downstream operations. Filling operations are changing in response to larger industry trends, explains Peter Soelkner, managing director of Vetter Pharma.
“Pharmaceutical development is evolving toward highly complex and sensitive biotech drugs including highly concentrated monoclonal antibodies and lyophilized products that present filling challenges that small molecule drugs, even parenterals and vaccines, do not.” ....
> Read the entire article at Genetic Engineering & Biotechnology News